The stable gastric pentadecapeptide BPC 157, an original cytoprotective antiulcer peptide that is used in ulcerative colitis and recently in a multiple sclerosis trial and that has an LD1 that has not been achieved [1,2,3,4,5,6,7,8,9,10,11], is known to have pleiotropic beneficial effects [1,2,3,4,5,6,7,8,9,10,11] and to interact with several molecular pathways [2, 27,28,29,30,31,32]
[18] FDAs review also noted that pharmaceutical development for obesity was subsequently terminated and that detailed study design and results were not available in the peer-reviewed medical literature
John DiBella Published: November 3, 2025 Fact-checked by Dr
GHK-CU 50mg is suited to smaller-scale studies, pilot experiments, and preliminary research programmes
Bacteria and mold can proliferate rapidly in unpreserved aqueous solutions, creating products that are unsafe to apply to your skin
Absolutely amazing service